Salvianolactone acid A isolated from Salvia miltiorrhiza ameliorates lipopolysaccharide-induced acute lung injury in mice by regulating PPAR-γ

被引:15
|
作者
Zhang, Qinqin [1 ,2 ]
Zeng, Mengnan [1 ,2 ,3 ,4 ]
Zhang, Beibei [1 ,2 ]
Ren, Yingjie [1 ,2 ]
Li, Shujing [1 ,2 ]
Wang, Ru [1 ,2 ]
Hu, Yingbo [1 ]
Fan, Ruyi [1 ]
Wang, Mengya [1 ]
Yu, Xiao [1 ]
Wu, Zhe [1 ]
Zheng, Xiaoke [1 ,2 ,3 ,4 ]
Feng, Weisheng [1 ,2 ,3 ,4 ]
机构
[1] Henan Univ Chinese Med, 156 Jinshui East Rd, Zhengzhou, Peoples R China
[2] Engn & Technol Ctr Chinese Med Dev Henan Prov, 156 Jinshui East Rd, Zhengzhou 450046, Peoples R China
[3] Henan Univ Chinese Med, Coconstruct Collaborat Innovat Ctr Chinese Med & R, Zhengzhou 450046, Peoples R China
[4] Henan Univ Chinese Med, Educ Minist PR, Zhengzhou, Peoples R China
关键词
Acute lung injury; PPAR-gamma; Salvianolactone acid A; Terpenoid;
D O I
10.1016/j.phymed.2022.154386
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Severe inflammation of the lungs results from acute lung injury (ALI), a common life-threatening lung disease with a high mortality rate. The ligand-activated transcription factor peroxisome proliferator-activated receptor (PPAR) gamma plays essential roles in diverse biological processes including inflammation, meta-bolism, development, and immune response. Salvianolactone acid A (SA) is a terpenoid derived from the herb Salvia miltiorrhiza. However, there is a scarcity of experimental evidence indicating whether the effect of SA on ALI occurs via PPAR-gamma. Methods: SA (20 or 40 mg/kg, i.g., 1 time/day) was administered to mice for 3 d, followed by the induction of ALI by intranasal lipopolysaccharide (LPS, 10 mg/kg). The lung function and levels of inflammation, reactive oxygen species (ROS), immune cells, apoptosis, and PPAR-gamma were examined. The antagonistic activity of GW9662 (GW, 1 mu M, specific PPAR-gamma blocker) and PPAR-gamma transfection silencing against SA (10 mu M) in BEAS-2B cells induced by LPS (10 mu g/ml, 24 h) was also investigated to assess whether the observed effects caused by SA were mediated by PPAR-gamma. Results: The results showed that lung histopathological injury, the B-line, the fluorescence intensity of live small animal, and the biomarkers in BALF or lung in the treatment of SA could regulate significantly. In addition, SA obviously decreased the levels of ROS and apoptosis in the primary lung cells, and MDA, increased the levels of GSH-Px and SOD. SA reduced levels of macrophages and neutrophils. Furthermore, SA reduced the protein levels of Keap-1, Cleaved-caspase-3, Cleaved-caspase-9, p-p65/p65, NLRP3, IL-1 beta, and upregulated the levels of p-Nrf2/Nrf2, HO-1, Bcl-2/Bax, PPAR-gamma, p-AMPK/AMPK in lung tissue. In addition, silencing and inhibition of PPAR-gamma effectively decreased the protective effects of SA in BEAS-2B cells induced by LPS, which might indicate that the active molecules of SA regulate ALI via mediation by PPAR-gamma, which exhibited that the effect of SA related to PPAR-gamma. Conclusions: The anti-ALI effects of SA were partially mediated through PPAR-gamma signaling. These data provide the molecular justification for the usage of SA in treating ALI and can assist in increasing the comprehensive utili-zation rate of Salvia miltiorrhiza.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-γ
    Shen, Yongbin
    Sun, Zhanfeng
    Guo, Xiaotong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 747 : 45 - 51
  • [2] Wogonoside Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice
    Zhang, Liang
    Ren, Yi
    Yang, Chengliang
    Guo, Yue
    Zhang, Xiaojing
    Hou, Gang
    Guo, Xinjin
    Sun, Nan
    Liu, Yongyu
    INFLAMMATION, 2014, 37 (06) : 2006 - 2012
  • [3] Wogonoside Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice
    Liang Zhang
    Yi Ren
    Chengliang Yang
    Yue Guo
    Xiaojing Zhang
    Gang Hou
    Xinjin Guo
    Nan Sun
    Yongyu Liu
    Inflammation, 2014, 37 : 2006 - 2012
  • [4] Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury
    Wang Qiushi
    Li Guanghua
    Xu Guangquan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 750 : 32 - 38
  • [5] Intranasal Curcumin Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice
    Kumari, Asha
    Tyagi, Namitosh
    Dash, D.
    Singh, Rashmi
    INFLAMMATION, 2015, 38 (03) : 1103 - 1112
  • [6] Hydrogen inhalation ameliorates lipopolysaccharide-induced acute lung injury in mice
    Qiu, Xiaochen
    Li, Hengyu
    Tang, Hongtai
    Jin, Yichao
    Li, Wuquan
    YuSun
    PingFeng
    Sun, Xuejun
    Xia, Zhaofan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (12) : 2130 - 2137
  • [7] Intranasal Curcumin Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice
    Asha Kumari
    Namitosh Tyagi
    D Dash
    Rashmi Singh
    Inflammation, 2015, 38 : 1103 - 1112
  • [8] Biochanin A protect against lipopolysaccharide-induced acute lung injury in mice by regulating TLR4/NF-κB and PPAR-γ pathway
    Hu, Xiansheng
    Qin, Hongyu
    Li, Yunpeng
    Li, Jingxian
    Fu, Lianjun
    Li, Musen
    Jiang, Cheng
    Yun, Jinyan
    Liu, Zhihu
    Feng, Yao
    Yao, Yuxuan
    Yin, Baishuang
    MICROBIAL PATHOGENESIS, 2020, 138
  • [9] Aurantiamide Acetate Ameliorates Lung Inflammation in Lipopolysaccharide-Induced Acute Lung Injury in Mice
    Fang, Zhengyu
    Fang, Jie
    Gao, Chunxiao
    Wu, Yueguo
    Yu, Wenying
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [10] Zanubrutinib ameliorates lipopolysaccharide-induced acute lung injury via regulating macrophage polarization
    Li, Xiaohe
    Wei, Yuli
    Li, Shimeng
    Liang, Jingjing
    Liu, Zhichao
    Cui, Yunyao
    Gao, Jingjing
    Yang, Zhongyi
    Li, Lei
    Zhou, Honggang
    Chen, Shanshan
    Yang, Cheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111